NO20002788L - Nye forbindelser - Google Patents
Nye forbindelserInfo
- Publication number
- NO20002788L NO20002788L NO20002788A NO20002788A NO20002788L NO 20002788 L NO20002788 L NO 20002788L NO 20002788 A NO20002788 A NO 20002788A NO 20002788 A NO20002788 A NO 20002788A NO 20002788 L NO20002788 L NO 20002788L
- Authority
- NO
- Norway
- Prior art keywords
- new connections
- preparation
- pharmaceutical compositions
- furano
- pyridazinones
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- SAQCYSFZOPGTOL-UHFFFAOYSA-N pyrazolo[3,4-d]pyridazin-3-one Chemical class N1=NC=C2C(=O)N=NC2=C1 SAQCYSFZOPGTOL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704542A SE9704542D0 (sv) | 1997-12-05 | 1997-12-05 | Novel pyridazinone compounds |
| SE9801989A SE9801989D0 (sv) | 1998-06-04 | 1998-06-04 | Novel compounds |
| PCT/SE1998/002191 WO1999029695A1 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002788D0 NO20002788D0 (no) | 2000-05-31 |
| NO20002788L true NO20002788L (no) | 2000-08-01 |
Family
ID=26663151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002788A NO20002788L (no) | 1997-12-05 | 2000-05-31 | Nye forbindelser |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6342601B1 (id) |
| EP (1) | EP1036076B1 (id) |
| JP (1) | JP2001525413A (id) |
| KR (1) | KR20010032769A (id) |
| CN (1) | CN1284079A (id) |
| AT (1) | ATE223413T1 (id) |
| AU (1) | AU1791699A (id) |
| BR (1) | BR9813373A (id) |
| CA (1) | CA2312419A1 (id) |
| DE (1) | DE69807741T2 (id) |
| EE (1) | EE200000318A (id) |
| HU (1) | HUP0100280A3 (id) |
| ID (1) | ID25628A (id) |
| IL (1) | IL136499A0 (id) |
| MX (1) | MXPA00005506A (id) |
| NO (1) | NO20002788L (id) |
| NZ (1) | NZ504452A (id) |
| PL (1) | PL340836A1 (id) |
| SK (1) | SK8402000A3 (id) |
| TR (1) | TR200001603T2 (id) |
| WO (1) | WO1999029695A1 (id) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801399D0 (sv) | 1998-04-21 | 1998-04-21 | Astra Pharma Prod | Method and apparatus for filling containers |
| US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
| EP1368349B1 (de) * | 2001-02-24 | 2007-02-14 | Boehringer Ingelheim Pharma GmbH & Co.KG | Xanthinderivate, deren herstellung und deren verwendung als arzneimittel |
| GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| GB0118479D0 (en) | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7569574B2 (en) | 2002-08-22 | 2009-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| US7495005B2 (en) | 2002-08-22 | 2009-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, their preparation and their use in pharmaceutical compositions |
| US7482337B2 (en) | 2002-11-08 | 2009-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| DE10254304A1 (de) | 2002-11-21 | 2004-06-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| MXPA05007495A (es) | 2003-01-17 | 2005-09-21 | Astrazeneca Ab | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. |
| SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| SE0300120D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| US7601718B2 (en) * | 2003-02-06 | 2009-10-13 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
| DE10327439A1 (de) * | 2003-06-18 | 2005-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| US7566707B2 (en) | 2003-06-18 | 2009-07-28 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| EP1697744A1 (en) * | 2003-11-21 | 2006-09-06 | AstraZeneca AB | Screening method |
| DE10355304A1 (de) | 2003-11-27 | 2005-06-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| US20070219178A1 (en) * | 2003-12-04 | 2007-09-20 | Eisai Co., Ltd. | Preventive or therapeutic agents for multiple sclerosis |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004009039A1 (de) | 2004-02-23 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel |
| US7393847B2 (en) | 2004-03-13 | 2008-07-01 | Boehringer Ingleheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
| US7179809B2 (en) * | 2004-04-10 | 2007-02-20 | Boehringer Ingelheim International Gmbh | 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| US7439370B2 (en) | 2004-05-10 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| DE102004030502A1 (de) | 2004-06-24 | 2006-01-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel |
| DE102004043944A1 (de) | 2004-09-11 | 2006-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004044221A1 (de) | 2004-09-14 | 2006-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1852108A1 (en) * | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| EP2540725A1 (de) | 2006-05-04 | 2013-01-02 | Boehringer Ingelheim International GmbH | Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin |
| JP2010500326A (ja) * | 2006-08-08 | 2010-01-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病の治療のためのｄｐｐ−ｉｖ阻害剤としてのピロロ［３，２−ｄ］ピリミジン |
| WO2009024542A2 (en) * | 2007-08-17 | 2009-02-26 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| NZ604091A (en) * | 2008-08-15 | 2014-08-29 | Boehringer Ingelheim Int | Purin derivatives for use in the treatment of fab-related diseases |
| CN102149407A (zh) | 2008-09-10 | 2011-08-10 | 贝林格尔.英格海姆国际有限公司 | 治疗糖尿病和相关病症的组合疗法 |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN102256976A (zh) | 2008-12-23 | 2011-11-23 | 贝林格尔.英格海姆国际有限公司 | 有机化合物的盐形式 |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| WO2011161161A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| JP6218811B2 (ja) | 2012-05-14 | 2017-10-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| US9200005B2 (en) | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| PT3442972T (pt) | 2016-04-15 | 2020-05-29 | Abbvie Inc | Inibidores de bromodomínio |
| CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
| GB202106872D0 (en) | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
| WO2023099648A1 (en) * | 2021-12-02 | 2023-06-08 | Astrazeneca Ab | Pyraolo- and triazolo-azinone compounds and their uses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1453897A (fr) * | 1965-06-16 | 1966-07-22 | Dérivés du thiophène et de thiéno pyridazines | |
| FR2478640A1 (fr) * | 1980-03-24 | 1981-09-25 | Sanofi Sa | Nouvelles thieno (2,3-d) pyridazinones-4 et thieno (2,3-d) pyridazinones-7, leur procede de preparation et leur therapeutique |
| JP3120857B2 (ja) * | 1990-02-19 | 2000-12-25 | 中外製薬株式会社 | 新規な縮合複素環化合物とこれを用いた抗喘息剤 |
| TW245719B (id) * | 1990-09-10 | 1995-04-21 | Sterling Winthrop Inc | |
| TW279162B (id) * | 1991-09-26 | 1996-06-21 | Mitsubishi Chem Corp | |
| US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
-
1998
- 1998-12-01 WO PCT/SE1998/002191 patent/WO1999029695A1/en not_active Ceased
- 1998-12-01 MX MXPA00005506A patent/MXPA00005506A/es not_active Application Discontinuation
- 1998-12-01 AT AT98962754T patent/ATE223413T1/de not_active IP Right Cessation
- 1998-12-01 JP JP2000524288A patent/JP2001525413A/ja not_active Withdrawn
- 1998-12-01 ID IDW20001021D patent/ID25628A/id unknown
- 1998-12-01 CN CN98813493A patent/CN1284079A/zh active Pending
- 1998-12-01 NZ NZ504452A patent/NZ504452A/en unknown
- 1998-12-01 TR TR2000/01603T patent/TR200001603T2/xx unknown
- 1998-12-01 EP EP98962754A patent/EP1036076B1/en not_active Expired - Lifetime
- 1998-12-01 BR BR9813373-0A patent/BR9813373A/pt not_active Application Discontinuation
- 1998-12-01 PL PL98340836A patent/PL340836A1/xx not_active Application Discontinuation
- 1998-12-01 SK SK840-2000A patent/SK8402000A3/sk unknown
- 1998-12-01 AU AU17916/99A patent/AU1791699A/en not_active Abandoned
- 1998-12-01 HU HU0100280A patent/HUP0100280A3/hu unknown
- 1998-12-01 KR KR1020007006064A patent/KR20010032769A/ko not_active Withdrawn
- 1998-12-01 DE DE69807741T patent/DE69807741T2/de not_active Expired - Fee Related
- 1998-12-01 EE EEP200000318A patent/EE200000318A/xx unknown
- 1998-12-01 IL IL13649998A patent/IL136499A0/xx unknown
- 1998-12-01 CA CA002312419A patent/CA2312419A1/en not_active Abandoned
-
1999
- 1999-01-12 US US09/214,755 patent/US6342601B1/en not_active Expired - Fee Related
-
2000
- 2000-05-31 NO NO20002788A patent/NO20002788L/no not_active Application Discontinuation
-
2001
- 2001-12-10 US US10/006,244 patent/US6770646B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999029695A1 (en) | 1999-06-17 |
| HUP0100280A2 (hu) | 2001-10-28 |
| KR20010032769A (ko) | 2001-04-25 |
| US20020099055A1 (en) | 2002-07-25 |
| NZ504452A (en) | 2002-05-31 |
| HUP0100280A3 (en) | 2003-03-28 |
| DE69807741D1 (de) | 2002-10-10 |
| ID25628A (id) | 2000-10-19 |
| CN1284079A (zh) | 2001-02-14 |
| PL340836A1 (en) | 2001-02-26 |
| US6342601B1 (en) | 2002-01-29 |
| NO20002788D0 (no) | 2000-05-31 |
| EP1036076A1 (en) | 2000-09-20 |
| IL136499A0 (en) | 2001-06-14 |
| BR9813373A (pt) | 2000-10-03 |
| JP2001525413A (ja) | 2001-12-11 |
| TR200001603T2 (tr) | 2000-10-23 |
| EP1036076B1 (en) | 2002-09-04 |
| ATE223413T1 (de) | 2002-09-15 |
| SK8402000A3 (en) | 2001-03-12 |
| DE69807741T2 (de) | 2004-07-15 |
| EE200000318A (et) | 2001-08-15 |
| US6770646B2 (en) | 2004-08-03 |
| CA2312419A1 (en) | 1999-06-17 |
| MXPA00005506A (es) | 2008-09-11 |
| AU1791699A (en) | 1999-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002788L (no) | Nye forbindelser | |
| NO995006L (no) | Nye forbindelser | |
| NO20000311L (no) | Nye forbindelser | |
| CA2263561A1 (en) | Thienopyrimidines | |
| MX9800215A (es) | Pirrolopirimidas y procesos para su preparacion. | |
| AU2094597A (en) | Pyrimido{5,4-d}pyrimidines, medicaments containing these compounds, their use and process for their production | |
| SE9702001D0 (sv) | Novel compounds | |
| WO2000012504A3 (de) | Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-on | |
| CA2272705A1 (en) | Fused bicyclic pyrimidine derivatives | |
| NO974151D0 (no) | 6-substituerte pyrazolo (3,4-d) pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav | |
| AU1925297A (en) | Pyrimido(5,4-d)pyrimidines, medicaments containing these compounds, their use and process for their production | |
| CA2181175A1 (en) | Dihydro Pyrazolopyrroles | |
| NO20000313L (no) | Nye forbindelser | |
| AU2097988A (en) | Imidazo (1,2-b) pyridazin-2-yl carbamate derivatives | |
| ATE35266T1 (de) | 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6dihydro-5-methyl-6-oxo-4h-imidazo(1,5a)(1,4)benzodiazepin, verfahren zu seiner herstellung und pharmazeutische zubereitungen. | |
| PL365824A1 (en) | Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders | |
| GB9410441D0 (en) | Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation | |
| MX9805321A (es) | Tieno[2,3-b]pirazolo[3,4-d]piridin-3-onas para incrementar la eritropoyesis. | |
| AU633193B2 (en) | Novel pyrrolo {1,2-a}thieno{3,2-f}{1,4}diazepines their process of preparation and the pharmaceutical compositions containing them | |
| MXPA03003199A (es) | 3,4-dihidro-pirimido?11,2-a]pirimidinas y 3,4-dihidro-pirazino[1,2-a?3 pirimidinas sustituidas. | |
| DE3576822D1 (de) | Pyrrolo(1,2-b)(1,2,5)triazepine, verfahren und zwischenprodukte zu ihrer herstellung und ihre anwendung als arzneimittel. | |
| MX9706878A (es) | Pirazolo [3,4-d] pirimidin-4-onas 6-arilo y composiciones y metodos para su uso. | |
| ES2062351T3 (es) | Derivados de triazolo (4,5-c) piridina anticonvulsivos. | |
| FI921091A0 (fi) | Menetelmä terapeuttisesti aktiivisen 2-fenyylisubstituoidun imidatso[1,5-a]kinoksaliini-1,3(2H,5H)-dionijohdannaisen valmistamiseksi | |
| HU905510D0 (en) | Process for producing pyrido(2,3-b)(1,5)benzoazepine (and thiazepine)- 5(6)-ones as well as -thiones and pharmaceutical preparatives containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |